跳至主要内容
临床试验/NL-OMON45074
NL-OMON45074已完成不适用

The effect of correction of metabolic acidosis in chronic kidney disease on intrarenal RAS activity. - BIC study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - male or female adult (>18 years)
  • - chronic kidney disease stage 4, i.e. eGFR (MDRD) 15-30 ml/min
  • - plasma bicarbonate concentration of <24 and >15 meq/L, the latter because in that case it seems highly recommended to start sodiumbicarbonate suppletion and not to postpone this

排除标准

  • - plasma bicarbonate level >24 meq/L or <15 meq/L
  • - sodiumbicarbonate use in the 6 months preceeding the study
  • - a kidney transplant in situ
  • - heart failure
  • - liver cirrhosis
  • - blood pressure > 140/90 mmHg despite the use of 3 different antihypertensives
  • - a history of inadherence to medication
  • - use of calcineurin inhibitors (these immunosuppressive drugs are known to induce metabolic acidosis and influence electrolytes and acid-base balance)

研究者

相似试验